477 related articles for article (PubMed ID: 29627951)
1. Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel.
Na'amnih W; Adler A; Miller-Roll T; Cohen D; Carmeli Y
Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1281-1288. PubMed ID: 29627951
[TBL] [Abstract][Full Text] [Related]
2. Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.
Kimura T; Snijder R; Sugitani T
J Infect Chemother; 2019 Aug; 25(8):615-620. PubMed ID: 30987950
[TBL] [Abstract][Full Text] [Related]
3. Incidence and Risk Factors for Community and Hospital Acquisition of Clostridium difficile Infection in the Tel Aviv Sourasky Medical Center.
Na'amnih W; Adler A; Miller-Roll T; Cohen D; Carmeli Y
Infect Control Hosp Epidemiol; 2017 Aug; 38(8):912-920. PubMed ID: 28558856
[TBL] [Abstract][Full Text] [Related]
4. Molecular types and antimicrobial susceptibility patterns of Clostridium difficile isolates in different epidemiological settings in a tertiary care center in Israel.
Miller-Roll T; Na'amnih W; Cohen D; Carmeli Y; Adler A
Diagn Microbiol Infect Dis; 2016 Dec; 86(4):450-454. PubMed ID: 27638350
[TBL] [Abstract][Full Text] [Related]
5. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a recurrent Clostridium difficile risk-prediction model.
Zilberberg MD; Reske K; Olsen M; Yan Y; Dubberke ER
J Hosp Med; 2014 Jul; 9(7):418-23. PubMed ID: 24700708
[TBL] [Abstract][Full Text] [Related]
7. Clinical, epidemiological and microbiological characteristics of relapse and re-infection in Clostridium difficile infection.
Gómez S; Chaves F; Orellana MA
Anaerobe; 2017 Dec; 48():147-151. PubMed ID: 28830842
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study.
Zilberberg MD; Reske K; Olsen M; Yan Y; Dubberke ER
BMC Infect Dis; 2014 Jun; 14():306. PubMed ID: 24898123
[TBL] [Abstract][Full Text] [Related]
9. Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics.
van Beurden YH; Nezami S; Mulder CJJ; Vandenbroucke-Grauls CMJE
Clin Microbiol Infect; 2018 Jan; 24(1):85.e1-85.e4. PubMed ID: 28782647
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients.
Scardina TL; Kang Martinez E; Balasubramanian N; Fox-Geiman M; Smith SE; Parada JP
Pharmacotherapy; 2017 Apr; 37(4):420-428. PubMed ID: 28226419
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.
Johnson S; Louie TJ; Gerding DN; Cornely OA; Chasan-Taber S; Fitts D; Gelone SP; Broom C; Davidson DM;
Clin Infect Dis; 2014 Aug; 59(3):345-54. PubMed ID: 24799326
[TBL] [Abstract][Full Text] [Related]
12. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
Daniel A; Rapose A
J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
[TBL] [Abstract][Full Text] [Related]
13. Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population.
Morrisette T; Van Matre AG; Miller MA; Mueller SW; Bajrovic V; Abidi MZ; Benamu E; Kaiser JN; Barber GR; Chase S; Tobin J; Fish DN; Gutman JA
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2091-2097. PubMed ID: 31255741
[TBL] [Abstract][Full Text] [Related]
14. Healthcare burden of recurrent Clostridioides difficile infection in Japan: A retrospective database study.
Kunishima H; Ito K; Laurent T; Abe M
J Infect Chemother; 2018 Nov; 24(11):892-901. PubMed ID: 30190105
[TBL] [Abstract][Full Text] [Related]
15. Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.
Nyc O; Tejkalova R; Kriz Z; Ruzicka F; Kubicek L; Matejkova J; Kuijper E; Krutova M
Microb Drug Resist; 2017 Jul; 23(5):609-615. PubMed ID: 27860531
[TBL] [Abstract][Full Text] [Related]
16. An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.
Bouza E; Alcalá L; Marín M; Valerio M; Reigadas E; Muñoz P; González-Del Vecchio M; de Egea V
Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1777-1786. PubMed ID: 28501926
[TBL] [Abstract][Full Text] [Related]
17. Potential impact of removing metronidazole from treatment armamentarium of mild acute
Zilberman-Itskovich S; Youngster I; Lazarovitch T; Bondarenco M; Toledano L; Kachlon Y; Mengesha B; Strul N; Zaidenstein R; Marchaim D
Future Microbiol; 2019 Nov; 14():1489-1495. PubMed ID: 31913060
[No Abstract] [Full Text] [Related]
18. Oral Vancomycin Monotherapy Versus Combination Therapy in Solid Organ Transplant Recipients With Uncomplicated Clostridium difficile Infection: A Retrospective Cohort Study.
Korayem GB; Eljaaly K; Matthias KR; Zangeneh TT
Transplant Proc; 2018; 50(1):137-141. PubMed ID: 29407296
[TBL] [Abstract][Full Text] [Related]
19. Risk of Clostridium difficile infection in hospitalized patients receiving metronidazole for a non-C difficile infection.
Rodriguez S; Hernandez MB; Tarchini G; Zaleski M; Vatanchi M; Cardona L; Castro-Pavia F; Schneider A
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1856-61. PubMed ID: 24681079
[TBL] [Abstract][Full Text] [Related]
20. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Wares KD; Sinclair C; Gould IM
Lancet Infect Dis; 2017 Feb; 17(2):194-206. PubMed ID: 27825595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
